Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00550147|
Recruitment Status : Completed
First Posted : October 29, 2007
Results First Posted : May 13, 2015
Last Update Posted : May 13, 2015
Indiana University School of Medicine
Information provided by (Responsible Party):
Indiana University ( Indiana University School of Medicine )
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Attention Deficit Disorder With Hyperactivity
Drug: Oros Methylphenidate
|Recruitment Details||Subjects were recruited during the time period 2004-2005, using flyers and letters sent to local schools, clinics, and community agencies, as well as from referrals to the site at which the study was conducted.|
|Pre-assignment Details||All eligible subjects were assigned to the first phase of treatment (Oros MPH alone).|
There were no unanticipated limitations/caveats. All of the typical caveats of open-label studies apply: As a result, bias, placebo effects, demand characteristics, and other non-treatment related effects may have contributed to results.